当前位置:首页 - 行情中心 - 云南白药(000538) - 财务分析 - 现金流量表

云南白药

(000538)

  

流通市值:889.75亿  总市值:889.81亿
流通股本:17.84亿   总股本:17.84亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金25,032,335,561.8611,422,833,440.7145,455,037,215.1634,139,590,066.27
  收到的税费返还-1,125,399.11,472,187.0911,120,849.574,498,810.86
  收到其他与经营活动有关的现金257,522,866.05110,575,265.78823,606,335.85548,346,727.77
  经营活动现金流入小计25,288,733,028.8111,534,880,893.5846,289,764,400.5834,692,435,604.9
  购买商品、接受劳务支付的现金16,381,571,633.988,228,743,395.531,295,057,710.6922,788,884,366.94
  支付给职工以及为职工支付的现金1,578,175,029.66947,425,765.793,084,089,638.032,275,472,927.96
  支付的各项税费1,229,014,992.42505,184,593.523,005,176,969.942,277,767,802.83
  支付其他与经营活动有关的现金1,993,932,004.421,024,511,019.434,305,746,201.482,894,340,995.63
  经营活动现金流出小计21,182,693,660.4810,705,864,774.2441,690,070,520.1430,236,466,093.36
  经营活动产生的现金流量净额4,106,039,368.33829,016,119.344,599,693,880.444,455,969,511.54
二、投资活动产生的现金流量:
  收回投资收到的现金3,850,000,0001,800,000,0006,651,743,736.654,395,828,996.48
  取得投资收益收到的现金119,011,633.21102,805,285.35321,151,517.75253,807,545.35
  处置固定资产、无形资产和其他长期资产收回的现金净额479,654.9384,280.91,153,813.56982,652.51
  处置子公司及其他营业单位收到的现金净额6,098,162.676,098,162.671,680,0001,680,000
  收到的其他与投资活动有关的现金665,731,155.6235,409,902.4966,194,049.98216,627,700
  投资活动现金流入小计4,641,320,606.382,144,697,631.327,941,923,117.944,868,926,894.34
  购建固定资产、无形资产和其他长期资产支付的现金222,045,750.52136,822,064.95479,661,609.93327,427,165.11
  投资支付的现金4,400,000,0002,400,000,0008,120,040,0006,200,040,000
  取得子公司及其他营业单位支付的现金--500,320,758.81-
  支付其他与投资活动有关的现金603,960,400135,286,400827,237,810554,847,010
  投资活动现金流出小计5,226,006,150.522,672,108,464.959,927,260,178.747,082,314,175.11
  投资活动产生的现金流量净额-584,685,544.14-527,410,833.63-1,985,337,060.8-2,213,387,280.77
三、筹资活动产生的现金流量:
  吸收投资收到的现金--84,483,323.3584,483,323.35
  其中:子公司吸收少数股东投资收到的现金--84,483,323.3584,483,323.35
  取得借款收到的现金--180,394,185.3813,885,245.55
  收到其他与筹资活动有关的现金23,985,516.955,014,543.1370,733,636.2657,844,575.62
  筹资活动现金流入小计23,985,516.955,014,543.13335,611,144.99156,213,144.52
  偿还债务支付的现金170,424,516.74156,579,491.9432,074,541.69427,280,181.54
  分配股利、利润或偿付利息支付的现金2,831,274,723.163,417,288.684,042,319,473.774,033,270,046.03
  其中:子公司支付给少数股东的股利、利润--10,838,079.036,829,443.26
  支付其他与筹资活动有关的现金64,503,613.6530,719,346.28210,208,928.13165,756,964.24
  筹资活动现金流出小计3,066,202,853.55190,716,126.864,684,602,943.594,626,307,191.81
  筹资活动产生的现金流量净额-3,042,217,336.6-185,701,583.73-4,348,991,798.6-4,470,094,047.29
四、汇率变动对现金及现金等价物的影响-10,320,105.79-5,634,105.73-8,661,908.99-6,359,311.98
五、现金及现金等价物净增加额468,816,381.8110,269,596.25-1,743,296,887.95-2,233,871,128.5
  加:期初现金及现金等价物余额8,532,232,687.398,532,234,667.7510,275,529,575.3410,275,529,575.34
  期末现金及现金等价物余额9,001,049,069.198,642,504,2648,532,232,687.398,041,658,446.84
补充资料:
  净利润3,697,247,984.17-5,189,940,856.98-
  资产减值准备-16,881,950.08-200,305,770.25-
  固定资产和投资性房地产折旧117,936,441.83-214,601,515.25-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧117,936,441.83-214,601,515.25-
  无形资产摊销21,163,222.72-30,458,268.65-
  长期待摊费用摊销20,000,133.54-56,277,022.29-
  处置固定资产、无形资产和其他长期资产的损失-3,051.83--8,167,595.81-
  固定资产报废损失-108,423.19-195,133.1-
  公允价值变动损失-129,325,396.89--110,489,468.71-
  财务费用10,236,543.28-32,955,118.48-
  投资损失-636,982,682.99--1,103,650,478.73-
  递延所得税-31,935,180.48--154,309,758.27-
  其中:递延所得税资产减少-47,647,947.47--208,859,943.48-
    递延所得税负债增加15,712,766.99-54,550,185.21-
  存货的减少59,459,218.25--72,254,087.27-
  经营性应收项目的减少913,107,195.15-349,815,291.54-
  经营性应付项目的增加28,149,471.9--139,126,220.96-
  现金的期末余额9,001,049,069.19-8,532,232,687.39-
  减:现金的期初余额8,532,232,687.39-10,275,529,575.34-
  现金及现金等价物的净增加额468,816,381.8--1,743,296,887.95-
公告日期2026-08-292026-04-302026-04-012025-10-31
审计意见(境内)标准无保留意见
TOP↑